PP
BSX icon

PDT Partners’s Boston Scientific BSX Stock Holding History

PDT Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,864
Closed -$750K – 537
2025
Q4 		$750K Sell
7,864
-24,252
-76% -$2.38M 0.05% 373
2025
Q3 		$3.14M Hold
32,116
– – 0.2% 178
2025
Q2 		$3.45M Buy
32,116
+9,516
+42% +$963K 0.2% 183
2025
Q1 		$2.28M Buy
22,600
+19,075
+541% +$1.92M 0.16% 217
2024
Q4 		$315K Buy
3,525
+25
+0.7% +$2.2K 0.03% 574
2024
Q3 		$293K Sell
3,500
-98
-3% -$7.72K 0.03% 609
2024
Q2 		$277K Buy
3,598
+98
+3% +$7.17K 0.03% 563
2024
Q1 		$240K Buy
+3,500
New +$225K 0.02% 561
2021
Q1 		– Sell
-15,100
Closed -$543K – 778
2020
Q4 		$543K Buy
+15,100
New +$544K 0.04% 437
2019
Q2 		– Sell
-787,300
Closed -$30.2M – 416
2019
Q1 		$30.2M Sell
787,300
-37,800
-5% -$1.44M 1.71% 5
2018
Q4 		$29.2M Sell
825,100
-65
-0% -$2.36K 1.63% 3
2018
Q3 		$31.8M Sell
825,165
-1,267
-0.2% -$44.3K 1.32% 7
2018
Q2 		$27M Sell
826,432
-278,751
-25% -$8.41M 1.03% 19
2018
Q1 		$30.2M Sell
1,105,183
-64,549
-6% -$1.75M 1.02% 9
2017
Q4 		$29M Buy
1,169,732
+317,532
+37% +$8.76M 0.84% 26
2017
Q3 		$24.9M Sell
852,200
-57,300
-6% -$1.58M 0.82% 20
2017
Q2 		$25.2M Buy
+909,500
New +$24.1M 1.01% 8
2013
Q4 		– Sell
-130,000
Closed -$1.53M – 687
2013
Q3 		$1.53M Buy
+130,000
New +$1.41M 0.04% 606

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PDT Partners's BSX Position: Q1 2026 in Review

PDT Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 7,864 shares — an estimated $750K sold.

PDT Partners first reported a position in BSX in Q3 2013 and held it in 18 quarters. The position peaked at $31.8M in Q3 2018. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • PDT Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 7,864 Boston Scientific shares in Q1 2026, an estimated $750K.
  • PDT Partners first reported a position in Boston Scientific in Q3 2013 and held it in 18 quarters.
  • PDT Partners's Boston Scientific position peaked at $31.8M in Q3 2018.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.